Where it stands
ILMN among the 60 companies we cover
Every dot is one of the 60 companies, the better end on the right. Hover a dot for the company.
ILMN and 9 peers, year by year
The 9 Health care companies closest to ILMN in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| ILMN Illumina, Inc. | FY2025 | $4.3B | −0.7% | 66.1% | 18.6% | 19.6% | 21.4% | 31.2% | 0.73 |
| IDXX Idexx Laboratories | FY2025 | $4.3B | +10.4% | 61.8% | 31.6% | 24.6% | 24.6% | 66.0% | 0.28 |
| COO Cooper Companies | FY2025 | $4.1B | +5.1% | 65.5% | 16.7% | 9.2% | 10.6% | 4.6% | 0.30 |
| MTD Mettler Toledo | FY2025 | $4.0B | +4.0% | 59.4% | - | 21.6% | 21.1% | n/m | n/m |
| ALGN Align Technology | FY2025 | $4.0B | +0.9% | 67.2% | 13.5% | 10.2% | 12.2% | 10.1% | - |
| CRL Charles River Laboratories | FY2025 | $4.0B | −0.9% | - | 0.6% | −3.6% | 12.9% | −4.6% | 0.68 |
| DXCM Dexcom | FY2025 | $4.7B | +15.6% | 60.1% | 19.6% | 17.9% | 23.1% | 30.5% | - |
| WAT Waters Corporation | FY2025 | $3.2B | +7.0% | - | 25.4% | 20.3% | 17.1% | 25.1% | 0.55 |
| VEEV Veeva Systems | FY2026 | $3.2B | +16.3% | 75.5% | 28.7% | 28.4% | - | 12.6% | - |
| WST West Pharmaceutical Services | FY2025 | $3.1B | +6.3% | 35.9% | 19.0% | 16.1% | 15.3% | 15.5% | 0.06 |
Revenue, FY2021 to FY2025
Revenue as reported in the 10-K.| Company | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| ILMN Dec | $4.5B | $4.6B | $4.5B | $4.4B | $4.3B |
| IDXX Dec | $3.2B | $3.4B | $3.7B | $3.9B | $4.3B |
| COO Oct | $2.9B | $3.3B | $3.6B | $3.9B | $4.1B |
| MTD Dec | $3.7B | $3.9B | $3.8B | $3.9B | $4.0B |
| ALGN Dec | $4.0B | $3.7B | $3.9B | $4.0B | $4.0B |
| CRL Dec | $3.5B | $4.0B | $4.1B | $4.0B | $4.0B |
| DXCM Dec | $2.4B | $2.9B | $3.6B | $4.0B | $4.7B |
| WAT Dec | $2.8B | $3.0B | $3.0B | $3.0B | $3.2B |
| VEEV Jan | $1.9B | - | $2.2B | $2.4B | $2.7B |
| WST Dec | $2.8B | $2.9B | $2.9B | $2.9B | $3.1B |
| Peer median | $2.9B | $3.3B | $3.6B | $3.9B | $4.0B |
Sales growth, FY2021 to FY2025
Revenue against the fiscal year before.| Company | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| ILMN Dec | +39.7% | +1.3% | −1.7% | −2.9% | −0.7% |
| IDXX Dec | +18.8% | +4.7% | +8.7% | +6.5% | +10.4% |
| COO Oct | +20.2% | +13.2% | +8.6% | +8.4% | +5.1% |
| MTD Dec | +20.5% | +5.4% | −3.4% | +2.2% | +4.0% |
| ALGN Dec | +59.9% | −5.5% | +3.4% | +3.5% | +0.9% |
| CRL Dec | +21.1% | +12.3% | +3.9% | −1.9% | −0.9% |
| DXCM Dec | +27.1% | +18.8% | +24.5% | +11.3% | +15.6% |
| WAT Dec | +17.8% | +6.7% | −0.5% | +0.1% | +7.0% |
| VEEV Jan | +26.3% | - | +16.4% | +9.7% | +16.2% |
| WST Dec | +31.9% | +2.0% | +2.2% | −1.9% | +6.3% |
| Peer median | +21.1% | +6.1% | +3.9% | +3.5% | +6.3% |
Gross margin, FY2021 to FY2025
Gross profit / revenue.| Company | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| ILMN Dec | 69.7% | 64.8% | 60.9% | 65.4% | 66.1% |
| IDXX Dec | 58.8% | 59.5% | 59.8% | 61.0% | 61.8% |
| COO Oct | 66.9% | 64.7% | 65.6% | 66.6% | 65.5% |
| MTD Dec | 58.4% | 58.9% | 59.2% | 60.1% | 59.4% |
| ALGN Dec | 74.3% | 70.5% | 70.1% | 70.0% | 67.2% |
| CRL Dec | - | - | - | - | - |
| DXCM Dec | 68.6% | 64.7% | 63.2% | 60.5% | 60.1% |
| WAT Dec | - | - | - | - | - |
| VEEV Jan | 72.8% | - | 71.7% | 71.3% | 74.5% |
| WST Dec | 41.5% | 39.4% | 38.3% | 34.5% | 35.9% |
| Peer median | 66.9% | 62.1% | 63.2% | 61.0% | 61.8% |
Operating margin, FY2021 to FY2025
Operating income / revenue.| Company | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| ILMN Dec | −2.7% | −91.2% | −23.7% | −19.1% | 18.6% |
| IDXX Dec | 29.0% | 26.7% | 30.0% | 29.0% | 31.6% |
| COO Oct | 17.3% | 15.3% | 14.8% | 18.1% | 16.7% |
| MTD Dec | - | - | - | - | - |
| ALGN Dec | 24.7% | 17.2% | 16.7% | 15.2% | 13.5% |
| CRL Dec | 16.7% | 16.4% | 14.9% | 5.6% | 0.6% |
| DXCM Dec | 10.9% | 13.4% | 16.5% | 14.9% | 19.6% |
| WAT Dec | 29.5% | 29.4% | 27.7% | 27.9% | 25.4% |
| VEEV Jan | 27.3% | - | 21.3% | 18.2% | 25.2% |
| WST Dec | 26.6% | 25.4% | 22.9% | 19.7% | 19.0% |
| Peer median | 25.6% | 17.2% | 19.0% | 18.1% | 19.3% |
Net margin, FY2021 to FY2025
Net income / revenue.| Company | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| ILMN Dec | 16.8% | −96.1% | −25.8% | −28.0% | 19.6% |
| IDXX Dec | 23.2% | 20.2% | 23.1% | 22.8% | 24.6% |
| COO Oct | 100.8% | 11.7% | 8.2% | 10.1% | 9.2% |
| MTD Dec | 20.7% | 22.3% | 20.8% | 22.3% | 21.6% |
| ALGN Dec | 19.5% | 9.7% | 11.5% | 10.5% | 10.2% |
| CRL Dec | 11.0% | 12.2% | 11.5% | 0.5% | −3.6% |
| DXCM Dec | 8.9% | 11.7% | 14.9% | 14.3% | 17.9% |
| WAT Dec | 24.9% | 23.8% | 21.7% | 21.6% | 20.3% |
| VEEV Jan | 23.1% | - | 22.6% | 22.2% | 26.0% |
| WST Dec | 23.4% | 20.3% | 20.1% | 17.0% | 16.1% |
| Peer median | 23.1% | 16.2% | 20.1% | 17.0% | 17.9% |
Free cash flow, FY2021 to FY2025
Cash from operations minus capital spending.| Company | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| ILMN Dec | $337.0M | $106.0M | $283.0M | $709.0M | $931.0M |
| IDXX Dec | $636.0M | $394.1M | $772.9M | $808.1M | $1.1B |
| COO Oct | $524.2M | $450.4M | $215.0M | $288.1M | $433.7M |
| MTD Dec | $801.2M | $737.8M | $860.6M | $864.4M | $848.6M |
| ALGN Dec | $771.4M | $276.8M | $608.1M | $622.7M | $490.8M |
| CRL Dec | $532.0M | $294.9M | $365.4M | $501.6M | $518.5M |
| DXCM Dec | $53.3M | $304.7M | $511.9M | $630.7M | $1.1B |
| WAT Dec | - | - | $442.2M | $619.6M | $539.8M |
| VEEV Jan | - | - | - | - | - |
| WST Dec | $330.6M | $439.4M | $414.5M | $276.4M | $468.9M |
| Peer median | $532.0M | $394.1M | $477.0M | $621.1M | $529.2M |
FCF margin, FY2021 to FY2025
Free cash flow / revenue.| Company | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| ILMN Dec | 7.4% | 2.3% | 6.3% | 16.2% | 21.4% |
| IDXX Dec | 19.8% | 11.7% | 21.1% | 20.7% | 24.6% |
| COO Oct | 17.9% | 13.6% | 6.0% | 7.4% | 10.6% |
| MTD Dec | 21.6% | 18.8% | 22.7% | 22.3% | 21.1% |
| ALGN Dec | 19.5% | 7.4% | 15.7% | 15.6% | 12.2% |
| CRL Dec | 15.0% | 7.4% | 8.8% | 12.4% | 12.9% |
| DXCM Dec | 2.2% | 10.5% | 14.1% | 15.6% | 23.1% |
| WAT Dec | - | - | 15.0% | 20.9% | 17.1% |
| VEEV Jan | - | - | - | - | - |
| WST Dec | 11.7% | 15.2% | 14.1% | 9.6% | 15.3% |
| Peer median | 17.9% | 11.7% | 14.5% | 15.6% | 16.2% |
Return on equity, FY2021 to FY2025
Net income / shareholders' equity at the year end.| Company | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| ILMN Dec | 7.1% | −66.7% | −20.2% | −51.5% | 31.2% |
| IDXX Dec | 107.9% | 111.6% | 56.9% | 55.7% | 66.0% |
| COO Oct | 42.4% | 5.4% | 3.9% | 4.9% | 4.6% |
| MTD Dec | n/m | n/m | n/m | n/m | n/m |
| ALGN Dec | 21.3% | 10.0% | 12.3% | 10.9% | 10.1% |
| CRL Dec | 15.4% | 16.3% | 13.2% | 0.6% | −4.6% |
| DXCM Dec | 10.6% | 16.0% | 26.2% | 27.4% | 30.5% |
| WAT Dec | 188.5% | 140.3% | 55.8% | 34.9% | 25.1% |
| VEEV Jan | 14.7% | - | 13.1% | 11.3% | 12.2% |
| WST Dec | 28.3% | 21.8% | 20.6% | 18.4% | 15.5% |
| Peer median | 24.8% | 16.3% | 16.9% | 14.8% | 13.9% |
Debt / equity, FY2021 to FY2025
Total debt / shareholders' equity at the year end.| Company | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| ILMN Dec | 0.09 | 0.30 | 0.26 | 0.84 | 0.73 |
| IDXX Dec | 1.23 | 1.26 | 0.47 | 0.39 | 0.28 |
| COO Oct | 0.21 | 0.38 | 0.34 | 0.32 | 0.30 |
| MTD Dec | 9.81 | n/m | n/m | n/m | n/m |
| ALGN Dec | - | - | - | - | - |
| CRL Dec | 1.05 | 0.91 | 0.74 | 0.65 | 0.68 |
| DXCM Dec | - | - | - | - | - |
| WAT Dec | 4.14 | 3.13 | 2.05 | 0.89 | 0.55 |
| VEEV Jan | - | - | - | - | - |
| WST Dec | 0.11 | 0.08 | 0.07 | 0.08 | 0.06 |
| Peer median | 1.14 | 0.91 | 0.47 | 0.39 | 0.30 |
EPS (diluted), FY2021 to FY2025
Diluted earnings per share, on today's share count after splits.| Company | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| ILMN Dec | $5.04 | −$28.00 | −$7.34 | −$7.69 | $5.45 |
| IDXX Dec | $8.60 | $8.03 | $10.06 | $10.67 | $13.08 |
| COO Oct | $14.79 | $1.94 | $1.48 | $1.96 | $1.87 |
| MTD Dec | $32.78 | $38.41 | $35.90 | $40.48 | $42.05 |
| ALGN Dec | $9.69 | $4.61 | $5.81 | $5.62 | $5.65 |
| CRL Dec | $7.60 | $9.48 | $9.22 | $0.20 | −$2.91 |
| DXCM Dec | $0.53 | $0.82 | $1.30 | $1.42 | $2.09 |
| WAT Dec | $11.17 | $11.73 | $10.84 | $10.71 | $10.76 |
| VEEV Jan | $2.63 | - | $3.00 | $3.22 | $4.32 |
| WST Dec | $8.67 | $7.73 | $7.88 | $6.69 | $6.79 |
| Peer median | $8.67 | $7.88 | $7.88 | $5.62 | $5.65 |
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out ILMN and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →
Work on ILMN in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/ILMN/export.csv") into a cell.